HLB Co., Ltd.

HLB Co., Ltd.

Share · KR7028300002 (XKOS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of HLB Co., Ltd.
No Price
Closing Price XKOS 29.04.2026: 63.000,00 KRW
29.04.2026 06:30
Current Prices from HLB Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
028300.KQ
KRW
29.04.2026 06:30
63.000,00 KRW
100,00 KRW
+0,16 %
Share Float & Liquidity
Free Float 91,47 %
Shares Float 120 M
Shares Outstanding 131,2 M
Invested Funds

The following funds have invested in HLB Co., Ltd.:

Fund
iShares MSCI Korea UCITS ETF USD (Acc)
Vol. in million
892,91
Percentage (%)
0,50 %
Fund
iShares MSCI Korea UCITS ETF (Dist)
Vol. in million
3.135,82
Percentage (%)
0,48 %
Fund
iShares MSCI EM ex-China UCITS ETF USD (Acc)
Vol. in million
16,46
Percentage (%)
0,10 %
Fund
iShares MSCI AC Far East ex-Japan UCITS ETF USD (Acc)
Vol. in million
16,86
Percentage (%)
0,08 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
188,86
Percentage (%)
0,06 %
Company Profile for HLB Co., Ltd. Share
HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea. The company offers conventional type lifeboats, free fall type lifeboats, and rescue boats. It also provides marine and yacht engines; hooks; RIB, patrol, fishing, aluminum, and leisure boats; fishery inspection ships; and safety goods, as well as lifeboat and davit inspection and repair services, service engineering training, and spare parts for lifeboats and davits. In addition, the company develops Riboseranib, a targeted anti-cancer agent; and Apilia that is used for the treatment for ovarian cancer. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.

Company Data

Name HLB Co., Ltd.
Company HLB Co., Ltd.
Website https://www.hlbkorea.com
Primary Exchange XKOS KOSDAQ
ISIN KR7028300002
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Baek Yoon Ki
Market Capitalization 8.252 Mrd.
Country South Korea
Currency KRW
Employees 0,2 T
Address 216-53, Dangwol-ro, 135-816 Ulsan
IPO Date 2008-12-24

Stock Splits

Date Split
02.08.2023 21:20
28.12.2022 521:500
13.10.2022 129:125
15.03.2021 2:1
05.06.2020 11:10
17.04.2020 513:500
10.12.2010 125000:2294551
28.07.2005 261:250
01.06.2005 1:5

Ticker Symbols

Name Symbol
KOSDAQ 028300.KQ
More Shares
Investors who hold HLB Co., Ltd. also have the following shares in their portfolio:
FONC. LY     EO 2
FONC. LY EO 2 Share
VIER GAS TRA. MTN19/34
VIER GAS TRA. MTN19/34 Bond